Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France
Clinical trial NCT05359276 · COMPLETED
Trial details
- NCT number
- NCT05359276
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-10
- Primary completion
- 2024-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.